Evidence map›Paper›PMID 40741103›Full record

GuidelineWorld journal of gastroenterology2025

First regional consensus on the management of

Ala I Sharara, Fahad I Alsohaibani, Ahmad Alsaegh, Khalid Al Ejji, Sameer Al Awadhi, Peter Malfertheiner, Sherif A Karam, Talal Al-Taweel

Abstract readConsensus StatementPractice Guideline
In one paragraph

Guideline in World journal of gastroenterology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Association of Resistance-AssociatedAntibiotics (Basel, Switzerland) · 2026
    Article
  2. Eradication rates of Helicobacter pylori regimens and predictors of treatment failure: A multicenter real-world study in Saudi Arabia.Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association · 2026
    Article
  3. Vitamin D status andFrontiers in nutrition · 2026
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ala I ShararaDepartment of Internal Medicine, American University of Beirut Medical Center, Beirut 961, Lebanon.
Fahad I AlsohaibaniDepartment of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh 11239, Saudi Arabia.
Ahmad AlsaeghDivision of Gastroenterology and Hepatology, Salmaniya Medical Complex, Manama 2904, Bahrain.
Khalid Al EjjiAmbulatory Care Center, Hamad Medical Corporation, Doha 3050, Qatar.
Sameer Al AwadhiDigestive Diseases Unit, Rashid Hospital, Dubai 4545, United Arab Emirates.
Peter MalfertheinerDepartment of Medical ІІ, University Hospital LMU Munich, Munich 81377, Germany.
Sherif A KaramBachelor of Pharmaceutical Sciences, October 6 University, 6th of October City Governorate 12511, Egypt.
Talal Al-TaweelDivision of Gastroenterology, Department of Internal Medicine, Jaber Al-Ahmad Hospital, Ministries Area 900015, Kuwait. taltaweel@moh.gov.kw.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsGastritisHelicobacter InfectionsHelicobacter pyloriAntimicrobial StewardshipConsensusDrug Resistance, BacterialDrug Therapy, CombinationHumansMicrobial Sensitivity TestsMiddle EastPrevalenceProton Pump InhibitorsAnti-Bacterial AgentsProton Pump InhibitorsAntibiotic resistanceConsensus guidelinesGastric cancerGut microbiotaHelicobacter pylori

Identifiers

PMID40741103
PMCPMC12305147

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.